CLLKF (BICO Group AB) Other Current Receivables: $5.1 Mil (As of Mar. 2026)


CLLKF BICO Group AB CLLKF
60 GF Score
Price $1.76
GF Value $3.67
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is BICO Group AB Other Current Receivables?

BICO Group AB CLLKF -7.36% 60 Other Current Receivables is $5.1 Mil as of Mar. 2026. GuruFocus rates CLLKF with a GF Score™ of 60/100 and a GF Value™ of $3.67 (Possible Value Trap). The stock has 4 warning signs investors should review.

BICO Group AB's Other Current Receivables for the quarter that ended in Mar. 2026 was $5.1 Mil.

BICO Group AB's quarterly Other Current Receivables increased from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($4.06 Mil) and increased from Dec. 2025 ($4.06 Mil) to Mar. 2026 ($5.09 Mil).

BICO Group AB's annual Other Current Receivables declined from Dec. 2023 ($5.62 Mil) to Dec. 2024 ($3.40 Mil) but then increased from Dec. 2024 ($3.40 Mil) to Dec. 2025 ($4.06 Mil).

BICO Group AB Other Current Receivables Related Terms

BICO Group AB Other Current Receivables Historical Data

* Premium members only.

The historical data trend for BICO Group AB's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BICO Group AB Other Current Receivables Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.25 21.23 5.62 3.40 4.06

BICO Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.19 0.00 0.00 4.06 5.09
CLLKF
60GF Score
BICO Group AB CLLKF
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BICO Group AB Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $5.1 Mil mean?
BICO Group AB (CLLKF) has a Other Current Receivables of $5.1 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on BICO Group AB and its competitors.
Is BICO Group AB's Other Current Receivables too high?
BICO Group AB's current Other Current Receivables is $5.1 Mil. Overall, BICO Group AB has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's Other Current Receivables compare to ABT and SYK?
BICO Group AB's Other Current Receivables of $5.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on BICO Group AB and its competitors. BICO Group AB's current Other Current Receivables is $5.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
Based on GuruFocus' analysis, BICO Group AB (CLLKF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.67, compared to a current price of $1.76 — trading 52% below its estimated fair value. The current Other Current Receivables is $5.1 Mil. BICO Group AB's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For BICO Group AB (CLLKF), the current Other Current Receivables is $5.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BICO Group AB (CLLKF) Overvalued in 2026?

Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued. The current stock price of $1.76 is trading 52% below its estimated GF Value™ of $3.67. GuruFocus considers BICO Group AB to be Possible Value Trap.

Key valuation signals for CLLKF:

  • Other Current Receivables: $5.1 Mil
  • GF Value™: $3.67 vs. price of $1.76 (52% below fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the CLLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BICO Group AB Business Description

Address Grafiska vagen 2B, Gothenburg, SWE, 412 63
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
60GF Score

Get the complete analysis for CLLKF

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.76
Price
$3.67
GF Value